Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 03 2023 - 6:17AM
Edgar (US Regulatory)
U.S.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of March 2023
Commission
File Number: 001-39137
AnPac
Bio-Medical Science Co., Ltd.
801
Bixing Street, Bihu County
Lishui,
Zhejiang Province 323006
The
People’s Republic of China
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXPLANATORY
NOTE
On
March 31, 2023, the Registrant issued a press release reporting that it has entered into a securities purchase agreement with certain
institutional investors to purchase $3 million of its American Depositary Shares (“ADSs”), pre-funded warrants to purchase
ADSs and warrants to purchase ADSs in a registered direct offering. The Registrant intends to use the net proceeds from the sale of the
securities for the advancement of its research and development activities, working capital and general corporate purposes.
EXHIBIT
INDEX
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
AnPac
Bio-Medical Science Co., Ltd. |
|
|
|
By: |
/s/Haohan
Xu |
|
Name: |
Haohan
Xu |
|
Title: |
Co-Chief
Executive Officer |
|
|
|
Dated:
March 31, 2023 |
|
|
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2024 to May 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From May 2023 to May 2024